Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
99
datasets available to search
ShareScore release 0.9.0
Dataset results
99 results for “cerebrovascular disease”
Vascular Ultrasound Screening in Patients With Ischemic Cerebrovascular Disease: a Multi-center Registry Study
ClinicalTrials.gov study NCT02397655. IPD Sharing: NO. Countries: 1. Publications: 3.
Diagnosis and Treatment of Sleep Apnea in Cerebrovascular Disease
ClinicalTrials.gov study NCT00984308. IPD Sharing: UNDECIDED. Countries: 1. Publications: 7.
Cerebrovascular alterations in a mouse model of late-onset Alzheimer's disease
Open the record for dataset details and reuse information.
Data from: An MRI measure of degenerative and cerebrovascular pathology in Alzheimer's disease
Objective: To develop, replicate, and validate an MRI-based quantitative measure of both cerebrovascular and neurodegeneration in Alzheimer's disease for clinical and potentially research purposes. Methods. We used data from a cross-sectional and longitudinal community-based study of Medicare-eligible residents in northern Manhattan followed every 18-24 months (N=1,175, mean age=78 years). White matter hyperintensities, infarcts, hippocampal volumes, and cortical thicknesses were quantified from MRI and combined to generate an MRI measure associated with episodic memory. The combined MRI measure was replicated and validated using autopsy data, clinical diagnoses, and cerebrospinal fluid biomarkers and amyloid PET from the Alzheimer's Disease Neuroimaging Initiative. Results. The quantitative MRI measure was developed in a group of community participants (n=690) and replicated in a similar second group (n=485). Compared with healthy controls, the quantitative MRI measure was lower in patients with mild cognitive impairment and lower still in those with clinically diagnosed Alzheimer's disease. The quantitative MRI measure correlated with neurofibrillary tangles, neuronal loss, atrophy, and infarcts at postmortem in an autopsy subset and was also associated with PET amyloid imaging and cerebrospinal fluid levels of total tau, p-tau, and Aβ42. The MRI measure predicted conversion to MCI and clinical Alzheimer's disease among healthy controls. Conclusions. We developed, replicated and validated an MRI measure of cerebrovascular and neurodegenerative pathologies that are associated with clinical and neuropathological diagnosis of Alzheimer's disease and related to established biomarkers.
Cerebrovascular disease progression in patients with ACTA2 Arg179 pathogenic variants supplementary materials
<p><span><span><span><span><span><span><span><span><span><span><span>Our study entitled "Cerebrovascular disease progression in patients with ACTA2 Arg179 Pathogenic Variants" examines progression of imaging biomarkers of stroke, arterial steno-occlusive disease and white matter injury in patients with smooth muscle dysfunction syndrome caused by mutations in the ACTA2 gene (ACTA2 Arg179 pathogenic variants). We found characteristic patterns of acute white matter ischemic injury and progressive internal carotid artery stenosis on MRI. Longitudinal analysis showed both stable and progressive lesion entities. The data was collected on various scanner setups. To eliminate potential bias related to improving imaging technology we re-analyzed imaging markers for those patients with available longitudinal imaging on an identical scanner setups and present the data in supplementary table e-1. Supplementary table e-2 shows results of a comparison of imaging markers between male and female sex.</span></span></span></span></span></span></span></span></span></span></span></p>
Fabry Disease in Cerebrovascular Disease
ClinicalTrials.gov study NCT02859363. IPD Sharing: NO. Countries: 1. Publications: 9.
Cerebrovascular Disease: Quality of Life (CODE: QoL)
ClinicalTrials.gov study NCT06443268. IPD Sharing: NO. Countries: 1. Publications: 23.
Fetal Cerebrovascular Autoregulation in Congenital Heart Disease and Association With Neonatal Neurobehavior
ClinicalTrials.gov study NCT05767385. IPD Sharing: NO. Countries: 1. Publications: 19.
Remimazolam and Endovascular Procedures of Cerebrovascular Diseases
ClinicalTrials.gov study NCT04950621. IPD Sharing: YES. Countries: 1. Publications: 3.
Functional Recovery Effects on Comprehensive Rehabilitation for Post-acute Care -Cerebrovascular Diseases
ClinicalTrials.gov study NCT02311036. IPD Sharing: Not stated. Countries: 1. Publications: 7.
The Imperial Comprehensive Cognitive Assessment in Cerebrovascular Disease (IC3)
ClinicalTrials.gov study NCT05885295. IPD Sharing: UNDECIDED. Countries: 1. Publications: 1.
RAre, But Not aLone: a Large Italian Network to Empower the Impervious diaGNostic Pathway of Rare cerEbrovascular Diseases (ALIGNED)
ClinicalTrials.gov study NCT06935578. IPD Sharing: NO. Countries: 1. Publications: 10.
National Database of the Virtual Institute of Cerebrovascular Diseases
ClinicalTrials.gov study NCT05925699. IPD Sharing: UNDECIDED. Countries: 1. Publications: 6.
Serum Adiponectin in Chinese Population and Its Correlation to Cardiovascular and Cerebrovascular Diseases
ClinicalTrials.gov study NCT01372800. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Aspirin Treatment for Small Unruptured InTracranial Aneurysms With Ischemic cereBrovascuLar diseasE
ClinicalTrials.gov study NCT05907902. IPD Sharing: UNDECIDED. Countries: 1. Publications: 2.
Nutrition and Physical Activity in Patients With Cerebrovascular Disease
ClinicalTrials.gov study NCT01146132. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Cerebrovascular Outcomes in Ischemic Heart Disease
ClinicalTrials.gov study NCT02715661. IPD Sharing: NO. Countries: 1. Publications: 11.
Comparing Effects of Various Combinations of 6 Hertz(Hz) rTMS & LFrTMS on Motor Recovery Due to Cerebrovascular Disease
ClinicalTrials.gov study NCT03012204. IPD Sharing: UNDECIDED. Countries: 1. Publications: 5.
Cerebrovascular Reactivity in Alzheimer's Disease
ClinicalTrials.gov study NCT03650816. IPD Sharing: NO. Countries: 1. Publications: 2.
Cerebrovascular disease progression in patients with ACTA2 Arg179 pathogenic variants supplementary materials
Open the record for dataset details and reuse information.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.